For media inquiries: Julie Rathbun Rathbun Communications julie@rathbuncomm.com 206-769-9219
February 6, 2025
Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn’s and Colitis Congress®
November 7, 2024
Mozart Therapeutics Announces Publication of MTX-101 Preclinical Data Demonstrating Modulation of Regulatory CD8 T Cell Network to Restore Immune Homeostasis
November 5, 2024
Mozart Therapeutics Announces Podium Presentation at Immunology of Diabetes Society Congress; Shows Potential for Lead Program, MTX-101, to Restore Insulin Production in Type 1 Diabetes
More news Releases
